Matches in Wikidata for { <http://www.wikidata.org/entity/Q37342927> ?p ?o ?g. }
- Q37342927 description "article científic" @default.
- Q37342927 description "article scientifique" @default.
- Q37342927 description "articolo scientifico" @default.
- Q37342927 description "artigo científico" @default.
- Q37342927 description "artículu científicu espublizáu en 2008" @default.
- Q37342927 description "bilimsel makale" @default.
- Q37342927 description "bài báo khoa học" @default.
- Q37342927 description "scientific article published on 20 June 2008" @default.
- Q37342927 description "vedecký článok" @default.
- Q37342927 description "vetenskaplig artikel" @default.
- Q37342927 description "videnskabelig artikel" @default.
- Q37342927 description "vědecký článek" @default.
- Q37342927 description "wetenschappelijk artikel" @default.
- Q37342927 description "wissenschaftlicher Artikel" @default.
- Q37342927 description "наукова стаття, опублікована в червні 2008" @default.
- Q37342927 description "научни чланак" @default.
- Q37342927 description "مقالة علمية نشرت في 20 يونيو 2008" @default.
- Q37342927 name "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 name "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 name "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 type Item @default.
- Q37342927 label "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 label "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 label "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 prefLabel "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 prefLabel "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 prefLabel "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 P1433 Q37342927-573933F3-0DEF-4091-ADA1-4A8DFF606739 @default.
- Q37342927 P1476 Q37342927-33C80D12-B42B-421C-8746-58B262A9A691 @default.
- Q37342927 P2093 Q37342927-1FE3F961-D8D5-4AB9-8A68-89A8CAF61853 @default.
- Q37342927 P2093 Q37342927-2A312166-7ABB-4E73-BB96-585C6D416345 @default.
- Q37342927 P2093 Q37342927-78A1CD73-D7D1-4590-8EFF-E707C8BE1663 @default.
- Q37342927 P2093 Q37342927-86B56213-383D-4F25-8BE1-AD91BABAEC16 @default.
- Q37342927 P2093 Q37342927-9C1C07C7-6D15-460C-BF8C-77F7DCC3A6D5 @default.
- Q37342927 P2093 Q37342927-C0538718-009B-4D12-A733-13DDB43BF799 @default.
- Q37342927 P2093 Q37342927-E3A176EC-2CAF-4332-B969-DA76ED5B556A @default.
- Q37342927 P2093 Q37342927-F2D45C01-7F51-481F-8C5D-03D2D3064D51 @default.
- Q37342927 P2093 Q37342927-F47A7078-0CDB-470A-8D89-6D77E1C0DAEB @default.
- Q37342927 P2860 Q37342927-02FA22D3-761C-418A-9B48-F2AA2D4C8830 @default.
- Q37342927 P2860 Q37342927-033EEB03-3085-49B9-9A2D-0FFE1F37594C @default.
- Q37342927 P2860 Q37342927-0B1780E2-E1D9-49ED-8EE5-095D6E18580F @default.
- Q37342927 P2860 Q37342927-0B92FBCA-95D8-40A1-B0CC-E769D831F667 @default.
- Q37342927 P2860 Q37342927-0FA00630-B623-4AF6-925E-C681D288084D @default.
- Q37342927 P2860 Q37342927-10758355-F885-46FC-B9CB-DD8DCA8A31CE @default.
- Q37342927 P2860 Q37342927-26E2CD31-B0BD-4EC5-9A7C-145CEFAA6AEB @default.
- Q37342927 P2860 Q37342927-28E12FB4-D11E-43EC-9C61-5988FD59D76C @default.
- Q37342927 P2860 Q37342927-2C1F3CBA-1A53-4522-BBEA-DA55CC04FBC5 @default.
- Q37342927 P2860 Q37342927-2EDDCD72-BE32-43BC-94F2-BF233CA7622F @default.
- Q37342927 P2860 Q37342927-35B05D19-B6C5-48B2-8B5E-B0B8226CC1A1 @default.
- Q37342927 P2860 Q37342927-3D4C6E0E-2804-4475-A3B8-68F93E177C1D @default.
- Q37342927 P2860 Q37342927-426B620F-FA82-44CB-85C6-5BFD5BA6383C @default.
- Q37342927 P2860 Q37342927-44BCABAA-0121-47E6-BCA5-EF4BE51DC29F @default.
- Q37342927 P2860 Q37342927-473C12DD-F4E9-4BFA-9AFC-5E53025A2F99 @default.
- Q37342927 P2860 Q37342927-4FC838F6-A80F-47C7-B1CA-F74D5BCF7961 @default.
- Q37342927 P2860 Q37342927-51BEB2E8-1BA0-4C85-BB11-793C54691159 @default.
- Q37342927 P2860 Q37342927-575FAC9C-0A19-435F-A09A-8F45BA9E0B95 @default.
- Q37342927 P2860 Q37342927-698E1179-CCCD-4875-94C0-E000D8B144E4 @default.
- Q37342927 P2860 Q37342927-80537073-7AEE-4B32-8431-4E7B8DC5944C @default.
- Q37342927 P2860 Q37342927-8554F6C8-9C39-47EB-9540-CA18D06FE1B7 @default.
- Q37342927 P2860 Q37342927-94846E49-FE67-48D0-A59D-257F08D4E8D2 @default.
- Q37342927 P2860 Q37342927-E8F6BBD6-EE4A-469C-BC3F-84BF7AB74525 @default.
- Q37342927 P2860 Q37342927-EA709017-16F6-4914-A06C-92FB2A094C30 @default.
- Q37342927 P2860 Q37342927-F61B87A6-737F-4C8C-98E7-297426FE8594 @default.
- Q37342927 P2860 Q37342927-F80E3AD1-5A4E-4AD2-BD6D-3380165D52B1 @default.
- Q37342927 P304 Q37342927-039E0A63-C354-42F2-92A2-E9D2F304037C @default.
- Q37342927 P31 Q37342927-8978B264-A9B9-4C77-A904-6D5B72418344 @default.
- Q37342927 P356 Q37342927-07C34930-5FDA-453F-9E8E-9BEE8EEDA065 @default.
- Q37342927 P433 Q37342927-47FCC207-EAF2-4368-A5FB-81C87C3F268E @default.
- Q37342927 P478 Q37342927-F226631F-9518-42D7-9177-6A86FFD2F978 @default.
- Q37342927 P50 Q37342927-1714EF87-5774-43B6-B24A-80B809563031 @default.
- Q37342927 P50 Q37342927-574F3E81-A91D-40FC-B842-6671835F735B @default.
- Q37342927 P50 Q37342927-6A5E3E26-5438-4184-9E51-A08DC3131C76 @default.
- Q37342927 P50 Q37342927-874EC59D-910B-4CC6-AE4F-3480109EC661 @default.
- Q37342927 P577 Q37342927-B2E5F100-F066-405A-A757-FF03803FF9A9 @default.
- Q37342927 P5875 Q37342927-E3ECF313-66B5-43DD-BDA8-B62D4CC6E52D @default.
- Q37342927 P698 Q37342927-2FA10FDA-D028-493D-8353-B04C1A8C2ED9 @default.
- Q37342927 P921 Q37342927-1F6338C9-36E4-4988-8AFA-D9D3ADF3A615 @default.
- Q37342927 P921 Q37342927-87F9D66F-5DC1-48CC-93F5-53410A881BE9 @default.
- Q37342927 P932 Q37342927-F8ED324F-09BE-4552-B63A-7689BAE7AE04 @default.
- Q37342927 P356 J.JAUT.2008.05.001 @default.
- Q37342927 P698 18571896 @default.
- Q37342927 P1433 Q15716783 @default.
- Q37342927 P1476 "High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis" @default.
- Q37342927 P2093 "George F Reed" @default.
- Q37342927 P2093 "Jack A Ragheb" @default.
- Q37342927 P2093 "Pushpa Sran" @default.
- Q37342927 P2093 "Randy Robinson" @default.
- Q37342927 P2093 "Ronald Buggage" @default.
- Q37342927 P2093 "Sam Dahr" @default.
- Q37342927 P2093 "Shree K Kurup" @default.
- Q37342927 P2093 "Steven Yeh" @default.
- Q37342927 P2093 "Zhuqing Li" @default.
- Q37342927 P2860 Q24541751 @default.
- Q37342927 P2860 Q24727581 @default.
- Q37342927 P2860 Q28254646 @default.
- Q37342927 P2860 Q33194554 @default.
- Q37342927 P2860 Q34579440 @default.
- Q37342927 P2860 Q34596171 @default.
- Q37342927 P2860 Q35945533 @default.
- Q37342927 P2860 Q36025876 @default.